ICPT

Intercept Pharmaceuticals Announces Completion of Enrollment in FLINT

[at noodls] – NEW YORK, Nov. 12, 2012 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel … moreView todays social media effects on ICPTView the latest stocks trending across Twitter. Click to view dashboard […]

Intercept Pharmaceuticals to Present Phase 2a Portal Hypertension Data at AASLD’s Liver Meeting

[at noodls] – NEW YORK, Nov. 8, 2012 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel … moreView todays social media effects on ICPTView the latest stocks trending across Twitter. Click to view dashboard […]

Intercept Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

[at noodls] – NEW YORK, Oct. 15, 2012 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics … moreView todays social media effects on ICPTView the latest stocks trending across Twitter. Click to view dashboard […]